MacroGenics Inc. (MGNX)
NASDAQ: MGNX
· Real-Time Price · USD
1.57
-0.05 (-3.09%)
At close: Aug 15, 2025, 3:59 PM
1.56
-0.64%
After-hours: Aug 15, 2025, 07:40 PM EDT
MacroGenics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -41.04M | -15.42M | 56.31M | -55.66M | -52.19M | -46.07M | 17.55M | 57.47M | -38.01M | 12.8M | -24.81M | -41.3M | -66.44M | -58.02M | -52.89M | -39.94M | -51.27M |
Depreciation & Amortization | 1.59M | 2.05M | 1.83M | 1.81M | 1.84M | 1.9M | 1.95M | 2.81M | 2.98M | 3.23M | 2.84M | 2.88M | 2.91M | 2.95M | 2.8M | 2.78M | 2.73M |
Stock-Based Compensation | 4.39M | 11.27M | 5.97M | 6.65M | 5.55M | 4.36M | 4.79M | 4.39M | 4.83M | 4.74M | 5.12M | 5.3M | 5.27M | 5.41M | 6.36M | 6.07M | 5.29M |
Other Working Capital | n/a | 52K | 401K | 7.29M | -7.45M | -4.96M | 11.16M | 4.24M | -1.79M | 51.59M | -1.1M | -15M | 16.88M | -17.01M | -1.91M | 23.52M | 2.26M |
Other Non-Cash Items | n/a | -38.93M | 160K | 14.23M | 1.24M | -10.46M | -49.81M | -99.83M | 194K | -337K | 1.92M | 16.31M | 334K | 433K | 2.06M | 441K | 367K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 2.79M | -1.86M | -929K | n/a | n/a | n/a | n/a | n/a | 340K | n/a | n/a | n/a |
Change in Working Capital | n/a | 2.63M | -4.11M | 3.02M | -149K | 12.72M | -7.86M | 34M | 17.17M | 8.88M | 5.51M | -17.41M | 226K | -5.42M | 26.88M | -15.05M | 13.85M |
Operating Cash Flow | -46.89M | -38.41M | 60.16M | -44.48M | -45.64M | -28.04M | -35.25M | -2.09M | -12.83M | 29.32M | -9.42M | -49.16M | -57.7M | -54.31M | -14.79M | -45.69M | -29.04M |
Capital Expenditures | -529K | -620K | -592K | -1.03M | -1.46M | -620K | -499K | -286K | -359K | -393K | -804K | -1.01M | -1.42M | -1.38M | -2.13M | -2.07M | -626K |
Cash Acquisitions | n/a | -80K | -80K | 80K | n/a | 28.39M | 10K | 54K | -28.45M | 5.39M | n/a | n/a | n/a | -54.25M | n/a | n/a | n/a |
Purchase of Investments | -7.92M | -13.79M | -4.89M | -8.01M | -50.5M | -22.47M | -69.18M | -130.74M | -17.3M | -45.15M | n/a | -21.38M | -54.08M | -66.43M | -47.23M | -23.66M | -93.88M |
Sales Maturities Of Investments | 18.35M | 15.88M | 41M | 56.4M | 76.75M | 61.91M | 36.14M | 17.5M | 45.75M | 39.75M | 72.75M | 45.43M | 37.01M | 54.25M | 46.75M | 39.55M | 60.25M |
Other Investing Acitivies | n/a | 40M | 160K | 80K | n/a | -28.39M | n/a | n/a | 28.45M | -5.39M | n/a | n/a | n/a | 54.25M | n/a | n/a | n/a |
Investing Cash Flow | 9.9M | 41.47M | 35.6M | 47.44M | 24.79M | 38.82M | -33.52M | -113.48M | 28.09M | -5.79M | 71.95M | 23.04M | -18.48M | -13.55M | -2.62M | 13.82M | -34.26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 306K | n/a | n/a | n/a | n/a | -14K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -282K | -4K | -74K | 625K | 248K | 332K | 49.91M | 59K | 99.5M | 274K | -14K | 263K | 37K | 800K | -645K | 2.35M | 2.46M |
Financial Cash Flow | -282K | 155K | -68K | 625K | 248K | 273K | 49.91M | 59K | 100.12M | 1.36M | -14K | 263K | 37K | 800K | 18.97M | 2.35M | 100.66M |
Net Cash Flow | -37.27M | 3.21M | 95.69M | 3.58M | -20.6M | 11.06M | -18.86M | -115.51M | 115.38M | 24.89M | 62.52M | -25.86M | -76.14M | -67.06M | 1.56M | -29.53M | 37.37M |
Free Cash Flow | -47.42M | -39.03M | 59.57M | -45.52M | -47.1M | -28.66M | -35.74M | -2.38M | -13.19M | 28.93M | -10.23M | -50.17M | -59.11M | -55.68M | -16.93M | -47.76M | -29.66M |